VALOR-HCM: Mavacamten in Obstructive Hypertrophic Cardiomyopathy

Поділитися
Вставка
  • Опубліковано 6 жов 2024

КОМЕНТАРІ • 3

  • @marymaryquitecontrary
    @marymaryquitecontrary 2 роки тому

    This was such a good, thorough summary of the progress toward mavacamten approval and its likely acceptance both by the FDA and patients. Thank you so much, gentlemen.

  • @davidmcnair8781
    @davidmcnair8781 2 роки тому

    I need this in my life

  • @rajeswarib5791
    @rajeswarib5791 Рік тому

    Sir,what is the treatment Ash,,+ predominant hyper trophy in mid cavity and LV apex